DK2774612T3 - 4-Methylpyrazolformuleringer - Google Patents

4-Methylpyrazolformuleringer

Info

Publication number
DK2774612T3
DK2774612T3 DK14150138.7T DK14150138T DK2774612T3 DK 2774612 T3 DK2774612 T3 DK 2774612T3 DK 14150138 T DK14150138 T DK 14150138T DK 2774612 T3 DK2774612 T3 DK 2774612T3
Authority
DK
Denmark
Prior art keywords
methylpyrazole
formulations
methylpyrazole formulations
Prior art date
Application number
DK14150138.7T
Other languages
English (en)
Inventor
Thomas E Daley
Olga Jarzebinski
Kathy Powell
Original Assignee
Horizon Orphan Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horizon Orphan Llc filed Critical Horizon Orphan Llc
Application granted granted Critical
Publication of DK2774612T3 publication Critical patent/DK2774612T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK14150138.7T 2009-12-07 2010-12-06 4-Methylpyrazolformuleringer DK2774612T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26738909P 2009-12-07 2009-12-07
EP10836472.0A EP2467136B1 (en) 2009-12-07 2010-12-06 4-methylpyrazole formulations

Publications (1)

Publication Number Publication Date
DK2774612T3 true DK2774612T3 (da) 2017-11-20

Family

ID=44145870

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14150138.7T DK2774612T3 (da) 2009-12-07 2010-12-06 4-Methylpyrazolformuleringer
DK10836472.0T DK2467136T3 (da) 2009-12-07 2010-12-06 4-methylpyrazolformuleringer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10836472.0T DK2467136T3 (da) 2009-12-07 2010-12-06 4-methylpyrazolformuleringer

Country Status (14)

Country Link
US (2) US9173850B2 (da)
EP (3) EP3300732A1 (da)
JP (1) JP5678088B2 (da)
KR (1) KR101464053B1 (da)
CN (1) CN102630162B (da)
AU (1) AU2010328375B2 (da)
DK (2) DK2774612T3 (da)
ES (2) ES2487634T3 (da)
HK (1) HK1201759A1 (da)
PH (1) PH12012500772A1 (da)
PT (2) PT2467136E (da)
SG (2) SG10201710156RA (da)
TW (1) TWI490209B (da)
WO (1) WO2011071805A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5800669B2 (ja) 2011-10-18 2015-10-28 大阪化成株式会社 抗菌・抗カビ性付与剤、繊維類加工剤及び抗菌・抗カビ性繊維類の製造方法
EP3323412A1 (en) * 2016-11-17 2018-05-23 Amalicon Holding AG Formulation comprising 4-methylpyrazole
KR102150040B1 (ko) * 2018-10-16 2020-08-31 한국과학기술원 4-메틸피라졸을 포함하는 간암 예방 또는 치료용 조성물
CN109452286B (zh) * 2018-11-12 2020-11-06 青岛大学 甲吡唑在杀灭松材线虫中的应用
CN109381458B (zh) * 2018-12-16 2020-09-01 李志武 甲吡唑及其盐在制备抗癫痫药物中的用途
TW202110437A (zh) * 2019-05-23 2021-03-16 美商希諾瓦有限責任公司 用於酒精誘發之皮膚潮紅之治療及緩解的組成物及方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197787B1 (en) * 1997-03-03 2001-03-06 Sanofi-Synthelabo Pharmaceutical formulations containing poorly soluble drug substances
US6120806A (en) * 1997-06-25 2000-09-19 Whitmire; David R. Oral formulations for controlled release of alcohol deterrents
FR2807645B1 (fr) * 2000-04-12 2005-06-03 Oreal Utilisation d'inhibiteurs de l'alcool deshydrogenase dans le traitement cosmetique des matieres keratiniques
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
ITBO20020284A1 (it) 2002-05-14 2003-11-14 Ima Spa Macchina opercolatrice
CN100548260C (zh) 2002-07-05 2009-10-14 盐野义胶囊股份有限公司 胶囊填充封口装置
ES2376238T3 (es) * 2003-08-29 2012-03-12 Veloxis Pharmaceuticals A/S Composiciones de liberación modificada comprendiendo tacrolimus.
WO2005020959A2 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
US20080021083A1 (en) * 2004-03-03 2008-01-24 Daley Thomas E 4-Methylpyrazole Formulations for Inhibiting Ethanol Intolerance

Also Published As

Publication number Publication date
CN102630162A (zh) 2012-08-08
AU2010328375B2 (en) 2015-08-27
EP2467136A1 (en) 2012-06-27
PT2774612T (pt) 2017-11-17
JP2013512930A (ja) 2013-04-18
SG10201710156RA (en) 2018-01-30
US20120244217A1 (en) 2012-09-27
ES2487634T3 (es) 2014-08-22
PT2467136E (pt) 2014-08-26
WO2011071805A1 (en) 2011-06-16
ES2646201T3 (es) 2017-12-12
EP2774612B1 (en) 2017-08-30
PH12012500772A1 (en) 2019-03-25
DK2467136T3 (da) 2014-08-11
SG181566A1 (en) 2012-07-30
US20160151332A1 (en) 2016-06-02
HK1201759A1 (en) 2015-09-11
KR101464053B1 (ko) 2014-11-20
EP2467136A4 (en) 2013-01-16
TWI490209B (zh) 2015-07-01
EP2774612A1 (en) 2014-09-10
CN102630162B (zh) 2014-07-09
US9173850B2 (en) 2015-11-03
AU2010328375A1 (en) 2012-04-05
TW201127816A (en) 2011-08-16
EP2467136B1 (en) 2014-05-07
JP5678088B2 (ja) 2015-02-25
KR20120115483A (ko) 2012-10-18
EP3300732A1 (en) 2018-04-04

Similar Documents

Publication Publication Date Title
NO2020017I1 (no) Siponimod
HRP20181347T1 (hr) Formulacije dvoslojne tablete
DE112010004215A5 (de) Hydrostataktor
DE112010002949A5 (de) Kupplungstastpunkte
BRPI1009465A2 (pt) Formulação
BRPI1008827A2 (pt) deisobutenizador
FIC20240018I1 (fi) Vamoroloni
BRPI1014968A2 (pt) subalargador
BR112013013695A2 (pt) derivado de pirazol
DE112010002728A5 (de) Turboinhalator
DE112010004249A5 (de) Spindelaktor
DE112009005323A5 (de) Hebelarmprüfmaschine
BR112012016923A2 (pt) Derivados de pirazol
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BR112012004964A2 (pt) girocóptero
BRPI1008070A2 (pt) tricianoboratos
SMT202100150T1 (it) Formulazioni migliorate
DE112010003255A5 (de) Fördergutverteiler
EP2454221A4 (en) cineole
BRPI1010159A2 (pt) bistuti
DK2467136T3 (da) 4-methylpyrazolformuleringer
BRPI1013462A2 (pt) Formulações herbicidas
BR112012003616A2 (pt) metilpirroloprimidinacarboxamidas
DE112010002351A5 (de) Klemmorrichtung
DE112010003843T8 (de) Lastansteuervorrichtung